Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
natalizumab 300 mg/15 mL Soln 15 mL Vial (CDM 40120) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 16, 2026 , from http://ppman.hank.ai/transparency/procedure/40120/by-state?code_type=CDM
“natalizumab 300 mg/15 mL Soln 15 mL Vial (CDM 40120) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/40120/by-state?code_type=CDM. Accessed
October 16, 2026 .
“natalizumab 300 mg/15 mL Soln 15 mL Vial (CDM 40120) by State,” HANK Price Transparency ,
accessed October 16, 2026 ,
http://ppman.hank.ai/transparency/procedure/40120/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
40120 — Natalizumab 300 Mg/15 Ml Soln 15 Ml Vial
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$345
National median
$88 – $22,177
IQR (p25 – p75)
27
hospitals filing
10
states
Walking in without insurance?
Cash / self-pay price
Cash median
$1,019
vs. negotiated
+195.3%
Hospitals reporting
36
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 40120 (CDM), with interquartile range
State Median p25 p75
FL $59,323 $42,649 $90,093
NE $17,107 $16,927 $17,287
CT $15,598 $6,201 $22,576
KS $1,454 $469 $3,247
NJ $345 $333 $440
PA $345 $332 $422
NV $81 $37 $110
TX $78 $49 $122
WI $51 $39 $60
NM $10 $10 $10